Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone for CNI Toxicity in Liver Transplant
NCT02883400Phase 4Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Dec 2014
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of spironolactone in nephrotoxicity, sponsored by Wake Forest University Health Sciences. Started Dec 2014; status: completed.
02
Drugs
spironolactone
03
Conditions
nephrotoxicity
Beyond the preview
Go deeper on NCT02883400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02883400.